Cloning and embryonic stem cells for regenerative medicine

Prof. dr. Tanja Dominko

CellThera, Inc., Southbridge and Bioengineering Institute, Worcester Polytechnic Institute, USA


Parkinsons, Alzheimers, diabetes and other degenerative diseases could be treated with cell transplantation of new and healthy cells. During the past years the field of regenerative medicine has been focusing on development of therapeutically useful cells from embryonic stem cells. While these cells hold a great potential, their ethicaly controversial derivation has revived research using adult stem cells. Recently, novel technologies have been developed that allow derivation of pluripotent cells from adult somatic tissues. This would allow for derivation of patient-specific, autologous cells for cell therapy. This presentation will discuss the possibilities for the future development of strategies for regenerative medicine.